Jpmorgan Chase & CO Connect Biopharma Holdings LTD Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 121 shares of CNTB stock, worth $225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121
Previous 121 -0.0%
Holding current value
$225
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$0.7 - $2.06 $16,387 - $48,226
-23,411 Reduced 99.49%
121 $0
Q3 2023

Nov 14, 2023
SELL
$0.65 - $1.18 $16,146 - $29,311
-24,840 Reduced 51.35%
23,532 $19,000
Q2 2023

Aug 11, 2023
SELL
$1.01 - $1.25 $30,476 - $37,718
-30,175 Reduced 38.42%
48,372 $54,000
Q1 2023

May 11, 2023
BUY
$0.82 - $1.32 $59,849 - $96,342
72,987 Added 1312.72%
78,547 $78,000
Q4 2022

Feb 13, 2023
BUY
$0.64 - $1.31 $1,593 - $3,261
2,490 Added 81.11%
5,560 $4,000
Q3 2022

Nov 14, 2022
BUY
$0.8 - $1.65 $2,254 - $4,649
2,818 Added 1118.25%
3,070 $4,000
Q2 2022

Aug 11, 2022
SELL
$0.56 - $3.25 $2,054 - $11,921
-3,668 Reduced 93.57%
252 $0
Q1 2022

May 11, 2022
BUY
$2.46 - $5.92 $2,587 - $6,227
1,052 Added 36.68%
3,920 $12,000
Q4 2021

Feb 10, 2022
BUY
$4.26 - $23.33 $12,217 - $66,910
2,868 New
2,868 $15,000

Others Institutions Holding CNTB

# of Institutions
20
Shares Held
2.63M
Call Options Held
0
Put Options Held
0
View Full List

About Connect Biopharma Holdings Ltd

CNTB Quotes by TradingView
  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $102M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email